Form 4 for MBIO MUSTANG BIO, INC.
Accepted 2021-07-08 00:00:00 ET · period of report 2021-06-17 · accession 0001104659-21-090242 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-08 | 2021-06-17 | MBIO | Litchman Manuel MD | Pres, CEO, Dir | A - Grant | $0.00 | +61.0K | 874.0K | +8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2021-06-17 | A | A | 61,000 | $0.00 | 874,035 | D | — | — | (F1) Each restricted stock unit represents the right to receive one share of Common Stock of Mustang Bio, Inc. The restricted stock units will vest at different times over a period of 4 years. (F2) Includes restricted stock units, which vest over various time periods. |